VU6028418, with the CAS number 2649803-05-2, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in neuroscience. It is classified as a selective inhibitor of certain protein targets, which may influence various biological pathways. The compound is characterized by its specific molecular structure, which includes functional groups that contribute to its biological activity. VU6028418 has been studied for its effects on neurotransmitter systems, particularly in relation to cognitive functions and neurodegenerative diseases. Its pharmacological profile suggests that it may modulate receptor activity, leading to potential therapeutic effects. However, detailed information regarding its solubility, stability, and toxicity is typically assessed during preclinical studies. As research continues, VU6028418 may provide insights into new treatment strategies for neurological disorders, although further investigation is necessary to fully understand its mechanisms and efficacy in clinical settings.

VU6028418

2649803-05-2: VU6028418, with the CAS number 2649803-05-2, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in neuroscience. It is classified as a selective inhibitor of certain protein targets, which may influence various biological pathways. The compound is characterized by its specific molecular structure, which includes functional groups that contribute to its biological activity. VU6028418 has been studied for its effects on neurotransmitter systems, particularly in relation to cognitive functions and neurodegenerative diseases. Its pharmacological profile suggests that it may modulate receptor activity, leading to potential therapeutic effects. However, detailed information regarding its solubility, stability, and toxicity is typically assessed during preclinical studies. As research continues, VU6028418 may provide insights into new treatment strategies for neurological disorders, although further investigation is necessary to fully understand its mechanisms and efficacy in clinical settings.

<p>VU6028418 is a highly selective, potent, orally active M4mAChR antagonist that acts on hM4 (IC50: 4.1 nM).</p>

CAS 2649803-05-2

VU6028418

VU6028418

Ref: TM-T71675